Adelis Equity Partners Becomes Majority Owner of Nordic BioSite Group

May 28, 2021

Adelis Equity Partners has acquired a majority stake in Nordic BioSite Group to accelerate the group's growth and pan‑European expansion of its life‑science research and diagnostics distribution platform. Tellacq Partners, together with the founders and management team, had built the group (including Nordic Biosite AB, Sanbio BV and Biomol GmbH); the parties did not disclose the purchase price.

Buyers
Adelis Equity Partners
Targets
Nordic BioSite Group
Sellers
Tellacq Partners, Founders, Management team
Location
Sweden
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.